AscellaHealth Expands Leadership Team to Accelerate Growth, Strengthen Operations and Advance Patient-Centric Solutions
Globe Newswire • Tue Feb 25 2025
BERWYN, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announced the appointment of two senior leaders: Clayton Edwards, RPh, MBA, Senior Vice President, Payer Business Unit and Carl T. Bertram, PharmD, MS, MBA, Senior Vice President, Pharma Business Unit.
BERWYN, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) – AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announced the appointment of two senior leaders: Clayton Edwards, RPh, MBA, Senior Vice President, Payer Business Unit and Carl T. Bertram, PharmD, MS, MBA, Senior Vice President, Pharma Business Unit. These strategic roles will be instrumental in driving performance across the organization, elevating client and partner experiences and advancing AscellaHealth’s mission to improve access to innovative therapies and enhance clinical outcomes for individuals with rare and complex conditions.
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.